Clinical Trials Logo

Clinical Trial Summary

This dose-finding study is being conducted to select the daily oral dose of estetrol (E4) for the treatment of vasomotor symptoms (VMS) in post-menopausal women.


Clinical Trial Description

Oestrogen therapy is the most consistently effective treatment used in the US and Europe for menopausal VMS. Following the safety issues reported in the primary Women's Health Initiative publications and with continued subject requests for treatment, a challenge to clinicians has been to identify the lowest effective dose of oestrogen for alleviating menopausal symptoms. In addition, it is a challenge to develop a safer oestrogen than those currently used.

For this purpose, the minimum effective dose (MED) of E4 has to be defined for the treatment of menopausal symptoms. The present study is intended to evaluate changes in frequency and in severity of moderate to severe VMS in order to define the MED.

Subjects will be randomly allocated to either treatment group (2.5 mg E4, 5 mg E4, 10 mg E4, 15 mg E4, or placebo) in a 1:1:1:1:1 ratio. All treatments (E4 or Placebo) will be administered once daily (QD) per os for at least 12 consecutive weeks until the last biological assessments (Day 90 maximum) have been performed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02834312
Study type Interventional
Source Donesta Bioscience
Contact
Status Completed
Phase Phase 2
Start date May 2016
Completion date January 22, 2018

See also
  Status Clinical Trial Phase
Completed NCT01141972 - The Role of Vitamin D in Menopause: Relationship to Menopausal Symptoms in Body Composition Phase 1
Completed NCT03756272 - Stellate Ganglion Block to Reduce Hot Flushes N/A
Recruiting NCT00906308 - A Study of MF101 in Postmenopausal Women Phase 3
Completed NCT01452373 - Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women Phase 3
Completed NCT01464697 - Progesterone for Perimenopausal Night Sweats Phase 3
Completed NCT01680900 - Vilazodone for Menopausal Hot Flashes N/A
Completed NCT00031720 - Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease Phase 2
Completed NCT02028702 - Alternative Treatments for Menopausal Women N/A
Terminated NCT03122301 - Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer Phase 2
Completed NCT02513329 - Stellate Ganglion Block (SGB) For Women for Breast Cancer Phase 2
Suspended NCT02907983 - Stellate Ganglion Blockade in Post-Menopausal Women Phase 2
Completed NCT01466998 - Menopausal Treatment Using Relaxation Exercises (MaTURE) N/A
Completed NCT01816360 - Aromatherapy and Yogatherapy for Hot Flashes N/A